Market Overview

Affymetrix Announces Microarray for Identifying and Subtyping Pathogenic E. coli Using Unique DNA Signatures

Affymetrix (NASDAQ: AFFX) announces the availability of a multi-genome
pathogen microarray, designed by the Food and Drug Administration's
Center for Food Safety and Applied Nutrition (CFSAN) and built by
Affymetrix, for the detection and identification of pathogenic E.
coli during foodborne outbreaks. These high density DNA-based
microarray assays, for use with the GeneAtlas®
Personal Microarray System, can detect, discriminate, and uniquely
identify strains of E. coli on food products, clinical
samples, and environmental samples in real-time outbreak situations.

This custom designed microarray contains tens of thousands of biomarkers
mined from over 250 E. coli whole genome sequences, making
it a true representation of the E. coli PanGenome. In
addition

See full press release

Posted-In: News Guidance Contracts Management Global

 

Most Popular

Related Articles (AFFX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free